Announcement on Passing of the Generic Drug Consistency Evaluation for Digoxin Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Chongqing Taiji Industry (Group) Co., Ltd. announced that its subsidiary, Southwest Pharmaceutical Co., Ltd., has received approval for Digoxin Injection after passing the consistency evaluation for generic drugs. The approval indicates that the drug meets the required quality and efficacy standards for generic medications. Digoxin Injection is used for treating heart failure and controlling heart rates in patients with certain heart conditions. The company highlighted the potential for increased market competitiveness and support in medical procurement due to this approval.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Passing of the Generic Drug Consistency Evaluation for Digoxin Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Chongqing Taiji Industry (Group) Co., Ltd. on 6ix
Follow Chongqing Taiji Industry (Group) into a list and get an email when it puts out news.
Follow Chongqing Taiji Industry (Group)